At Truking Technology’s headquarters in Ningxiang, Hunan, automated guided vehicles operate with millimeter precision across the 40,000-square-meter production facility. High-speed aseptic filling lines for prefilled syringes are running continuously, demonstrating a systematic shift from traditional manufacturing to intelligent pharmaceutical engineering.

From June 27 to 29, 2025, more than 130 executives from nearly 30 countries visited Truking’s site during the company’s Open House event. The three-day program provided a close-up view of Truking’s efforts to build a digitally enabled pharmaceutical manufacturing ecosystem, particularly in support of the industrialization of novel therapeutics.

Integrated Solutions Across the Biopharmaceutical Lifecycle

Truking’s subsidiaries—including Romaco (Germany), Truking Microspheres, and Truking SUT—support a broad range of requirements in biopharmaceutical development and manufacturing. The company’s product portfolio covers key process steps from early-stage R&D to full-scale commercial production.

For example, Truking SUT develops single-use bioreactor bags used in cell culture, built with proprietary 11-layer composite film that emphasizes biological safety, mechanical strength, and low extractables. Such products are increasingly critical to the evolving needs of bioprocessing.

Truking Microspheres focuses on chromatography resins and has obtained DMF filings with the US FDA for several products. These are now used in the purification of biologics including proteins, antibodies, and gene therapy materials. Together, Truking’s bioprocess solutions aim to address core consumable needs across laboratory, pilot, and production-scale settings.

Responding to Industry Trends with Modular and Digital Systems

Ongoing shifts in drug production—such as smaller batch sizes, diversified indications, and strict sterility requirements—are prompting equipment manufacturers to provide more flexible and intelligent systems.

At Truking’s facility, visitors observed automated sterile filling lines operating in enclosed isolators, completing processes such as vial washing, sterilization, filling, capping, and packaging. These systems are already in use by major pharmaceutical firms in China.

The company also applies SCADA, MES, and digital twin technologies to enhance traceability, quality control, and system maintainability. Through digital modeling and virtual simulation, Truking aims to provide greater transparency and responsiveness throughout the manufacturing process.

Expanding International Footprint through Strategic Collaboration

Since acquiring Romaco in 2017, Truking has been operating with two centers, one in China focusing on R&D and system integration, and the other in Germany contributing advanced engineering and market access in Europe and the Americas.

This collaboration has improved product adaptability and market responsiveness. In 2024, Truking’s overseas orders exceeded RMB 1.2 billion, and its systems are now deployed in over 40 countries. The company continues to align closely with Romaco’s sales channels and technical networks.

A participant from an Indian pharmaceutical firm shared how Truking’s single-use systems helped them optimize upstream purification processes and accelerate project timelines, highlighting the importance of application-specific solutions in global biomanufacturing.

Looking Ahead: Strengthening Capacity and Global Reach

Truking is investing in enhanced delivery mechanisms, technical alignment, and after-sales support to meet the expectations of international partners. Each overseas project is supported by a dedicated account team, with pre-shipment validation and system testing conducted at the factory level.

Chairman and CEO Tang Yue notes that the company aims to further build its global presence by creating a mutually reinforcing cycle between its China and Germany operations—combining system integration with high-specification manufacturing and localized support.

Several multinationals have initiated supplier assessments, and Truking is working to meet their requirements for global procurement frameworks.

The company’s goal is clear: to become a globally recognized brand by 2030—one that contributes to the modernization of biomanufacturing infrastructure worldwide, through practical solutions and sustained collaboration.